Gapping up
In reaction to strong earnings/guidance:
- MTSI +12.7%, GE +6.2%, MSTR +5.6%, SC +5.5%, DT +5%, GLW +5%, MINI +4.9%, MXIM +4.2%, CMRE +2.8%, DOW +2.6%, WRB +2.1%, SYK +1.8%, AAPL +1.6%, MKSI +1.4%, MPC +1.3%, NDAQ +1.2%, BA +1.2%, SMG +1.1%, SWK +1%, RES +0.9%, NVR +0.7%, NYCB +0.6%, EXTR +0.6%, NVS +0.5%, TXT +0.5%, GD +0.5%
Other news:
- CTSO +13.6% (announces approval and availability of CytoSorb for the removal of ticagrelor during surgery requiring CPB in the EU)
- LB +11% (CEO Leslie Wexner aims to step aside amid push for strategic alternatives at Victoria's Secret, according to WSJ)
- ORTX +7.8% (receives orphan drug designation from the FDA for OTL-102)
- SRNE +6.7% (announces manufacturing collaboration with Celularity to initiate emergency allogeneic NK cell therapy development for coronavirus infection)
- TEVA +2.9% (FDA approval for AJOVY injection autoinjector device)
Analyst comments:
- FB +1.6% (upgraded to Strong Buy from Outperform at Raymond James)
- HOG +0.9% (upgraded to Sector Weight from Underweight at KeyBanc Capital Markets)